Dr Dunn leads a discussion outlining frontline therapies for the treatment of vitiligo. Jeffrey D. Dunn, PharmD, MBA: What therapies are being used? Are they generally covered by different books of ...
(“STRATA” or the “Company”), a global leader in excimer laser therapy dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today ...
Many patients with vitiligo remain untreated, and those who are treated receive short, variable therapies, researchers report.
Vitiligo is an autoimmune condition that causes areas of skin to lose color or pigment. It isn’t just visible to others. You can see it on yourself. And I talk with people all the time about how this ...
I’ve been a vitiligo researcher for almost 20 years. While it affects people of all races and ethnicities equally, it’s more visible in people with darker skin tones. As a result, they may be more ...
ATLANTA - At 57, Perry Whaley has been living with vitiligo, an autoimmune disorder that has caused him to lose pigment in his skin, for more than half his life. Whaley said, if he had been offered a ...
For patients who had 12 months of continuous health care coverage before and after receiving a diagnosis of vitiligo, treatment rates were at suboptimal levels. Using data from the Merative MarketScan ...
The FDA approved Incyte’s Opzelura topical cream, known as ruxolitinib, to treat vitiligo in patients 12 and older Vanessa Etienne is a Staff Writer for PEOPLE on the Health team. She joined the brand ...
Vitiligo is an autoimmune condition that targets the melanocytes, which are the skin cells that produce melanin and give your skin its color. Areas of your skin affected by vitiligo show up as white ...
Like many other chronic health conditions, vitiligo is often misunderstood—and due to the visible symptoms it causes, it’s undeniably stigmatized. Vitiligo is a chronic autoimmune condition that ...
Hosted on MSN
EDSA: Advancing EB06 for the Treatment of Vitiligo…
Edesa Biotech, Inc. (NASDAQ:EDSA) is planning for a Phase 2 study of its anti-CXCL10 monoclonal antibody for the treatment of moderate-to-severe non-segmental vitiligo patients. Vitiligo is a disease ...
Add Yahoo as a preferred source to see more of our stories on Google. Sarah Hayden owns a lot of turtlenecks. She also has chunky necklaces and tons of makeup – anything to cover up the blotchy white ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results